These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19423549)

  • 1. Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.
    Chambers R; Takimoto T
    J Gen Virol; 2009 Aug; 90(Pt 8):1906-1915. PubMed ID: 19423549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.
    Bousse T; Chambers RL; Scroggs RA; Portner A; Takimoto T
    Virus Res; 2006 Oct; 121(1):23-32. PubMed ID: 16677733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.
    Kato A; Kiyotani K; Kubota T; Yoshida T; Tashiro M; Nagai Y
    J Virol; 2007 Apr; 81(7):3264-71. PubMed ID: 17215288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.
    Bartlett EJ; Cruz AM; Esker J; Castaño A; Schomacker H; Surman SR; Hennessey M; Boonyaratanakornkit J; Pickles RJ; Collins PL; Murphy BR; Schmidt AC
    J Virol; 2008 Sep; 82(18):8965-77. PubMed ID: 18614629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1.
    Van Cleve W; Amaro-Carambot E; Surman SR; Bekisz J; Collins PL; Zoon KC; Murphy BR; Skiadopoulos MH; Bartlett EJ
    Virology; 2006 Aug; 352(1):61-73. PubMed ID: 16750233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.
    Irie T; Nagata N; Igarashi T; Okamoto I; Sakaguchi T
    PLoS One; 2010 May; 5(5):e10719. PubMed ID: 20502666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.
    Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner.
    Strähle L; Garcin D; Le Mercier P; Schlaak JF; Kolakofsky D
    J Virol; 2003 Jul; 77(14):7903-13. PubMed ID: 12829830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
    Zhan X; Slobod KS; Krishnamurthy S; Luque LE; Takimoto T; Jones B; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2008 Jun; 26(27-28):3480-8. PubMed ID: 18499307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.
    Hara H; Hara H; Hironaka T; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Falsey AR; Kamali A; Anzala O; Sanders EJ; Karita E; Mwananyanda L; Vasan S; Lombardo A; Parks CL; Sayeed E; Krebs M; Cormier E; Ackland J; Price MA; Excler JL
    Hum Vaccin; 2011 Jun; 7(6):639-45. PubMed ID: 21508675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3.
    Elco CP; Guenther JM; Williams BR; Sen GC
    J Virol; 2005 Apr; 79(7):3920-9. PubMed ID: 15767394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.
    Wetzel JL; Fensterl V; Sen GC
    J Virol; 2014 Dec; 88(23):13593-601. PubMed ID: 25231314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
    Jones B; Zhan X; Mishin V; Slobod KS; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2009 Mar; 27(12):1848-57. PubMed ID: 19200447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells.
    Iwasaki M; Yanagi Y
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15384-9. PubMed ID: 21896767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paramyxovirus accessory proteins as interferon antagonists.
    Gotoh B; Komatsu T; Takeuchi K; Yokoo J
    Microbiol Immunol; 2001; 45(12):787-800. PubMed ID: 11838896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins.
    Strähle L; Marq JB; Brini A; Hausmann S; Kolakofsky D; Garcin D
    J Virol; 2007 Nov; 81(22):12227-37. PubMed ID: 17804509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
    Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
    Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling.
    Odkhuu E; Komatsu T; Naiki Y; Koide N; Yokochi T
    Int Immunopharmacol; 2014 Nov; 23(1):267-72. PubMed ID: 25242386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation.
    Kato A; Cortese-Grogan C; Moyer SA; Sugahara F; Sakaguchi T; Kubota T; Otsuki N; Kohase M; Tashiro M; Nagai Y
    J Virol; 2004 Jul; 78(14):7443-54. PubMed ID: 15220418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.